As a visionary surgeon, he engaged with interventional colleagues, jointly designing and executing randomized comparisons between intervention and surgery. His contributions to the advancement of less invasive surgery have set in motion irreversible changes in surgical practice.
Professor Mohr trained in Germany at the Universities of Berlin and Bonn, as well in Australia at the University of New South Wales, Sydney, before taking up a residency in cardiovascular surgery in Bonn. He was also a fellow in the Department of Cardiology at Cedars Sinai in Los Angeles, where he learned the techniques of coronary laser angioplasty and angioscopy. He opted to pursue a career as a cardiac surgeon, but maintained a strong interest in cardiology.
Upon returning to Germany, Prof. Mohr worked first worked in Bonn, and then Goettingen in 1990, where he helped establish a heart transplantation program. In 1994, he created the Leipzig Heart Center, now one of the world’s leading centers for innovative techniques. In the late 1990s, Prof. Mohr and Prof. Carpentier pioneered the robotic technique for mitral valve repair and coronary bypass surgery.
Friedrich Mohr was among the first to acknowledge the achievements of interventional cardiology and to establish multidisciplinary Heart Teams. Early on, he became a promoter of catheter-based valve implantations. He held a leading role in the SYNTAX study, which has become a landmark trial for coronary revascularization and he was also involved in the PARTNER Trial on TAVI.
Professor Mohr is a past president of the German Society of Thoracic and Cardiovascular Surgery, the German Society of Cardiology and the Society of Heart Valve Disease. He has received numerous prizes and awards, including the Federal Cross of Merit of Germany, First Class (2010), which is the highest civilian award in Germany for political, economic, cultural, intellectual, and voluntary work, to honor outstanding performance.